Philip Sutera; Matthew P. Deek; Kim Van der Eecken; Alexander W. Wyatt; Amar U. Kishan; Jason K. Molitoris; Matthew J. Ferris; M. Minhaj Siddiqui; Zaker Rana; Mark V. Mishra; Young Kwok; Elai Davicioni; Daniel E. Spratt; Piet Ost; Felix Y. Feng; Phuoc T. Tran

Untitled

Genetic alterations in hepatocellular carcinoma: An update

World Journal of Gastroenterology 22(41) (2016)

Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang

Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling

Evidence-Based Complementary and Alternative Medicine 2022 (2022)

Shuai Lin; Qianwen Sheng; Xiaobin Ma; Shanli Li; Peng Xu; Cong Dai; Meng Wang; Huafeng Kang; Zhijun Dai; Yoshiki Mukudai

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Clinical Oncology 33(6) (2015)

Andrew X. Zhu; Olivier Rosmorduc; T.R. Jeffry Evans; Paul J. Ross; Armando Santoro; Flair Jose Carrilho; Jordi Bruix; Shukui Qin; Paul J. Thuluvath; Josep M. Llovet; Marie-Aude Leberre; Markus Jensen; Gerold Meinhardt; Yoon-Koo Kang

Precise Immunodetection of PTEN Protein in Human Neoplasia

Cold Spring Harbor Perspectives in Medicine 9(12) (2019)

Rafael Pulido; Janire Mingo; Ayman Gaafar; Caroline E. Nunes-Xavier; Sandra Luna; Leire Torices; Javier C. Angulo; José I. López

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

Molecules 27(17) (2022)

Monica A. Kamal; Yasmine M. Mandour; Mostafa K. Abd El-Aziz; Ulrike Stein; Hend M. El Tayebi

miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis

OncoTargets and Therapy Volume 14 (2021)

Yaqian Niu; Fang Liu; Xiuyue Wang; Yuling Chang; Yanmei Song; Huiyuan Chu; Shisan Bao; Che Chen

Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy

Seminars in Radiation Oncology 28(4) (2018)

Florence K. Keane; Theodore S. Hong; Andrew X. Zhu

Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma

Journal of Cellular Physiology 234(7) (2019)

Shalaimaiti Shali; Jiangang Yu; Xin Zhang; Xue Wang; Youping Jin; Minsheng Su; Xiaohong Liao; Jerry Yu; Xiuling Zhi; Ping Zhou

Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome

Oncotarget 10(20) (2019)

Ge Yan; Mohamed E.M. Saeed; Sebastian Foersch; Jose Schneider; Wilfried Roth; Thomas Efferth

Untitled

Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems

Tumor Biology 36(1) (2015)

Jing-Jun Yan; Jia-Zhi Liao; Ju-Sheng Lin; Xing-Xing He

Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma

Oncology Reports 31(6) (2014)

LI-LI HAN; HAO-CHENG NAN; TAO TIAN; HUI GUO; TING-HUA HU; WEN-JUAN WANG; JIE-QUN MA; LI-LI JIANG; QIAN-QIAN GUO; CHENG-CHENG YANG; XIAO-MIN KANG; YING LIU; YUAN GAO; QI-LUN LIU; KE-JUN NAN

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Oncology 94(6) (2018)

Melanie B. Thomas; Elizabeth Garrett-Mayer; Munazza Anis; Kate Anderton; Tricia Bentz; Andie Edwards; Alan Brisendine; Geoffrey Weiss; Abby B. Siegel; Johanna Bendell; Ari Baron; Vinay Duddalwar; Anthony El-Khoueiry

Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century

Hepatitis Monthly 13(2) (2013)

Behzad Yeganeh; Mohammad Hashemi; Fredrick J. de Serres; Marek J. Los; Saeid Ghavami

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

Cellular Signalling 26(5) (2014)

Dali Zhao; Bo Zhai; Changjun He; Gang Tan; Xian Jiang; Shangha Pan; Xuesong Dong; Zheng Wei; Lixin Ma; Haiquan Qiao; Hongchi Jiang; Xueying Sun

Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization

Genetic Testing and Molecular Biomarkers 20(4) (2016)

Xu-Cai Wang; Fan Wang; Qing-Qing Quan

EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma

Scientific Reports 6(1) (2016)

Chuangye Han; Xiwen Liao; Wei Qin; Long Yu; Xiaoguang Liu; Gang Chen; Zhengtao Liu; Sicong Lu; Zhiwei Chen; Hao Su; Guangzhi Zhu; Zili Lu; Zhiming Liu; Xue Qin; Ying Gui; Zengnan Mo; Lequn Li; Tao Peng